How Long Does It Take to Lose 3 Stone on Mounjaro?

Your starting weight changes the maths completely

Three stone sounds like a fixed target, but it is a moving percentage. Start at 22 stone and losing 3 stone means shifting roughly 13% of your body weight. Start at 16 stone and the same 3 stone is nearly 19%. That distinction matters because Mounjaro's trial results are reported as percentages. The SURMOUNT-1 trial, published in the New England Journal of Medicine, recorded average body-weight reductions of around 20–21% at the highest dose over 72 weeks. If 3 stone is 13% of your starting weight, the trial evidence suggests most people would reach it well before the 72-week mark. If it is closer to 20%, you are right at the outer edge of the average range.

There is a common assumption that the slowest losers simply need a higher dose. In practice, the bigger predictor is the percentage target relative to starting weight. A heavier starting point often means 3 stone arrives sooner in calendar terms, even if the total journey is longer. That is worth knowing before you set expectations.

For a sense of how a smaller target compares, losing 2 stone on Mounjaro follows the same percentage logic and typically falls within the first half of the treatment period for most people at licensed doses.

The dose titration schedule and what it means for your timeline

Mounjaro starts at 2.5mg. That first pen is not the one doing the heavy lifting on weight, its job is to let your body adjust to the medicine before the dose climbs. Titration typically moves in roughly 4-week steps through 5mg, 7.5mg, 10mg, 12.5mg and up to 15mg, guided by your prescriber and how you are tolerating each level.

The practical consequence is that meaningful weight loss usually becomes most noticeable from around week 8 onwards, once you are past the starter phase. Many people find the rate picks up again each time the dose increases, then steadies before the next step. This staged pattern means the first 12 weeks are rarely the most productive for weight loss, even though they can feel discouraging if you are watching the scales daily.

NICE's appraisal of tirzepatide (TA1026) notes that continuing treatment is reviewed if less than 5% weight loss has occurred after six months at the highest tolerated dose. If you are tracking your own progress, that 5% at six months is a clinically meaningful checkpoint, not a pass-or-fail. A prescriber interprets it in context. For people aiming for a larger goal, losing 4 stone on Mounjaro tends to require reaching and sustaining higher doses for longer.

Lifestyle factors that affect pace, and what the evidence actually says about them

The SURMOUNT-1 results were achieved alongside a reduced-calorie diet and increased physical activity, that is the licensed context for Mounjaro, not an optional add-on. Appetite reduction is real and pronounced for most people on tirzepatide, which makes eating less considerably easier than willpower alone. But protein intake, hydration and maintaining some resistance exercise all influence how much of that weight reduction comes from fat rather than muscle mass. That distinction matters for long-term health and for how you feel during treatment.

Sleep, stress and underlying metabolic conditions (thyroid function, insulin resistance) also influence individual pace. None of this should be read as a reason to expect failure, it is a reason to work with a prescriber and, where appropriate, a dietitian rather than comparing your week-8 results to someone else's. How quickly Mounjaro starts working and how long that first phase lasts are questions worth understanding before you start, so the early weeks feel less ambiguous. Cost context is worth considering too; Mounjaro pricing in the UK has changed significantly since mid-2025, so checking current figures before you plan a budget makes sense.

A realistic 3-stone timeline based on trial data

Translating percentages into calendar time requires some honest hedging, but the trial data does give a usable frame. In SURMOUNT-1, participants reached roughly 8–10% average loss by week 20 and were still losing steadily at week 72 at the higher doses. Someone for whom 3 stone is around 15% of starting weight could, based on that trajectory, expect to reach the target somewhere between 9 and 18 months of continuous treatment at an effective dose, with considerable individual variation either side.

Faster loss is more common in people with a higher starting BMI, those who reach 15mg without significant dose-limiting side effects, and those who make consistent dietary changes alongside treatment. Slower loss is more common when titration stalls, side effects require dose pauses, or the percentage target is at the higher end of the trial range. Tracking results through Mounjaro treatment and understanding what the early signals mean can help you and your prescriber make informed decisions about pace. If you are curious how ambitions beyond 3 stone might play out, the picture for losing 5 stone involves much longer timeframes and typically requires sustained treatment at maintenance doses.

If you would like a prescriber to review your specific situation and discuss what a realistic timeline might look like for you, speak to our prescribers through a free consultation, reviewed the same day by a GPhC-registered clinician, with no obligation to proceed.